Medtech Acquisition Corp.-CWTLSIWPreferred / convertible
13F holders, Q3 2025 (September 30)4holders −1
0new positions
0sold out
1famous investor
$1.58avg. 13F price*
At the end of Q3 2025, 4 institutions reported holding Medtech Acquisition Corp.-CW (TLSIW) in their 13F filings, down 1 from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($199K), Vestcor Inc ($111K) and B & T Capital Management DBA Alpha Capital Management ($19K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Medtech Acquisition Corp.-CW
- Filed as
- TRISALUS LIFE SCIENCES INC (Q3 2025)
- CUSIP
- 89680M119
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 103,336 shares bought and 15,435 shares sold, net +87,901 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Citadel Advisors | — | Add +439.0% | 126,876 | $199K |
| Vestcor Inc | — | No change | 70,832 | $111K |
| B & T Capital Management DBA Alpha Capital Management | — | Reduce -50.5% | 11,000 | $19K |
| Toronto Dominion Bank | — | Reduce -44.9% | 5,170 | $8K |
"% of holder's portfolio" is TLSIW's weight in each manager's 13F, not the share of Medtech Acquisition Corp.-CW the manager owns.